Yanfeng Liang

N. Jinming Ave
Kaifeng, 475004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Shikonin sensitises osimertinib-resistant lung adenocarcinoma to ferroptosis through HES1-mediated ATF3 upregulation.

Shikonin sensitises osimertinib-resistant lung adenocarcinoma to ferroptosis through HES1-mediated ATF3 upregulation.

Journal: Acta biochimica et biophysica Sinica

Published: July 09, 2026

SIN3A promotes lung adenocarcinoma by repressing MIR22HG/Beclin1 axis-mediated autophagy and ferroptosis.

SIN3A promotes lung adenocarcinoma by repressing MIR22HG/Beclin1 axis-mediated autophagy and ferroptosis.

Journal: European journal of medical research

Published: September 19, 2025

The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicing.

The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicing.

Journal: Oncogene

Published: September 08, 2025

Tremella polysaccharide alleviated the toxicity of bisphenol A on Caenorhabditis elegans via regulation of IIS/MAPK/skn-1 pathways and increasing antioxidant ability.

Tremella polysaccharide alleviated the toxicity of bisphenol A on Caenorhabditis elegans via regulation of IIS/MAPK/skn-1 pathways and increasing antioxidant ability.

Journal: Ecotoxicology and environmental safety

Published: September 06, 2025

The mechanism of luteolin suppressing pancreatic cancer (PC) via cyclin B1 (CCNB1)-mediated signalling.

The mechanism of luteolin suppressing pancreatic cancer (PC) via cyclin B1 (CCNB1)-mediated signalling.

Journal: Scientific reports

Published: July 30, 2025

Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions.

Nanomedicine breakthroughs overcoming pancreatic cancer drug resistance through precision nano-interventions.

Journal: Nanoscale advances

Published: May 25, 2025

Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC).

Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC).

Journal: Nanoscale

Published: March 07, 2025

Knockdown of MIR205HG prevents cell proliferation, migration and invasion through autophagy and ferroptosis pathways in lung adenocarcinoma.

Knockdown of MIR205HG prevents cell proliferation, migration and invasion through autophagy and ferroptosis pathways in lung adenocarcinoma.

Journal: Translational cancer research

Published: November 22, 2024

Showing 1-8 of 8

Last Updated: 09/26/2026